Oura expands Menopause Impact Scale and appoints independent directors
'Smart' ring maker Oura has announced the expansion of its proprietary Menopause Impact Scale (MIS) and its appointment of a number of independent directors. It says its MIS is now integrated with Alloy Health, Oova, Xella, Pomelo, Wisp, Maven, Mira, Hertility, Gennev and Tia. Extending the MIS beyond the Oura App into clinical and health workflows aims to give women and their medical practitioners a more consistent way to track menopause effects and make more informed treatment decisions.